GROBTEA vs INDOUS: Stock Comparison

The Grob Tea Company Limited vs Indo Us Biotech Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Indo Us Biotech Limited is the larger company by market capitalisation. Indo Us Biotech Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of The Grob Tea Company Limited and Indo Us Biotech Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GROBTEA is more favourable on 3 of 11 scored metrics and INDOUS on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
INDOUS is the larger company
₹170 Cr vs ₹105 Cr
EPS
GROBTEA has higher earnings per share
₹49.53 vs ₹6.54
Dividend Yield
INDOUS has a higher dividend yield
0.29% vs 0.22%
Revenue Growth (TTM YoY)
INDOUS has faster revenue growth
-22% vs -39.6%
EPS Growth (TTM YoY)
GROBTEA has faster EPS growth
0% vs -47.3%
Qtr Sales Growth
INDOUS has stronger quarterly sales growth
5.64% vs -39.5%
Qtr Profit Growth
GROBTEA has stronger quarterly profit growth
3.13% vs -24%
ROE
INDOUS has a higher ROE
16.9% vs 6.82%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGROBTEAINDOUS
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryTea & CoffeeOther Agricultural Products

Price

MetricGROBTEAINDOUS
Live Price₹899.8₹84.98
Day Change1.36%-2.24%
Volume1917,311
52-Week High₹1,236.2₹182.1
52-Week Low₹805₹84.91
Distance from 52W High-27.21%-53.33%

Valuation

MetricGROBTEAINDOUS
Market Cap₹105 Cr₹170 Cr
P/E Ratio0x
P/B Ratio0x
EPS₹49.53₹6.54
Book Value₹798.48₹45.99
Dividend Yield0.22%0.29%

Growth

MetricGROBTEAINDOUS
Revenue Growth (TTM YoY)-39.6%-22%
EPS Growth (TTM YoY)0%-47.3%
Qtr Sales Growth-39.5%5.64%
Qtr Profit Growth3.13%-24%

Profitability & Leverage

MetricGROBTEAINDOUS
ROE6.82%16.9%
ROCE7.36%15.4%
Net Margin5.03%11.88%
Operating Margin6.25%13.8%
Debt to Equity0.57x0.33x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricGROBTEAINDOUS
Promoter Holding74.99%68.29%
FII Holding0%0.01% 0.17 pp
DII Holding0.06%
Public Holding24.95%31.7% 0.17 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: The Grob Tea Company Limited and Indo Us Biotech Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.